In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...

ROCHESTER, N.Y. — Rochester Regional Health has launched a free genetic screening program for adults called Genowell. Participants can learn about inherited risks of breast, ovarian, and colon cancers ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its third quarter ended September 30, 2025 and reaffirmed ...